Atea Pharmaceuticals, Inc. (AVIR) Operating margin 2021–2022
Atea Pharmaceuticals, Inc. (AVIR) operating margin by fiscal year — reported operating income divided by reported revenue.
-37.2%FY2022 · since FY2021: 284.5% → -37.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -37.2% | -321.7 pp |
| FY2021 | 284.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AVIR financial trends
AVIR RevenueAVIR Net incomeAVIR Net marginAVIR Gross profitAVIR Gross marginAVIR Operating incomeAVIR Operating cash flowAVIR Free cash flowAVIR Capital expendituresAVIR Return on equityAVIR Stock buybacksAVIR Dividends paidAVIR Total assetsAVIR Total liabilitiesAVIR Shareholders’ equityAVIR overview →